Bio-Communications Research Institute

The Bio-Communications Research Institute (BCRI) is the research division of the Riordan Clinic, a world-renowned center for orthomolecular medicine and nutritional therapy. Founded in 1975 by Dr. Hugh Riordan, the institute is a global leader in the study of high-dose intravenous Vitamin C and its applications in oncology and chronic disease management. BCRI's primary mission is to investigate the biochemical and physiological effects of nutrients on human health, particularly focusing on the 'Riordan IVC Protocol.' Their research has provided foundational evidence for the selective cytotoxicity of Vitamin C against cancer cells and its role in immune system modulation. The institute operates as a non-profit entity, collaborating with academic institutions to advance integrative medical practices. Through clinical trials and laboratory studies, BCRI continues to develop evidence-based nutritional protocols to improve patient outcomes and quality of life.